Existing Drugs Offer Hope Against Widespread Liver Disease
October 07, 2025
Researchers are repurposing existing medications to combat metabolic dysfunction-associated steatotic liver disease, a prevalent condition affecting one in three adults globally. This approach, which utilizes existing drugs, appears to be both cost-effective and promising in mitigating one of the most common liver disorders worldwide.